GWAS |
- Apolipoprotein A1 levels ( 32203549)
- Basal cell carcinoma ( 31174203)
- Body mass index ( 26426971)
- Coronary artery disease ( 29212778)
- Keratinocyte cancer (MTAG) ( 31174203)
- LDL cholesterol levels ( 32203549)
- Medication use (agents acting on the renin-angiotensin system) ( 31015401)
- Red cell distribution width ( 27863252)
|
- Adolescent idiopathic scoliosis ( 28334814)
- Asthma ( 27611488)
- Asthma (childhood onset) ( 27611488)
- Body size at age 10 ( 32376654)
- Brain morphology (min-P) ( 32665545)
- Brain morphology (MOSTest) ( 32665545)
- Cobalt levels ( 26025379)
- Coronary artery calcified atherosclerotic plaque score in type 2 diabetes ( 29221444)
- Cortical surface area (MOSTest) ( 32665545)
- Crohn's disease-related phenotypes ( 25557950)
- Homeostasis model assessment of beta-cell function (dietary factor interaction) ( 24204828)
- Knee osteoarthritis ( 28916551)
- Neurociticism ( 29500382)
- Neuroticism ( 25993607)
- Nicotine dependence symptom count ( 25555482)
- Ocular sarcoidosis ( 32141793)
- Ocular sarcoidosis in sarcoidosis ( 32141793)
- Post bronchodilator FEV1/FVC ratio ( 26634245)
- PR interval ( 23534349)
- Pre-treatment viral load in HIV-1 infection ( 31219150)
- Refractive error ( 32231278)
- Subcortical volume (min-P) ( 32665545)
- Subcortical volume (MOSTest) ( 32665545)
|